Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-097131
Filing Date
2022-09-01
Accepted
2022-09-01 20:38:54
Documents
1
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2225015-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2225015-3_4seq1.xml 4 3563
  Complete submission text file 0001104659-22-097131.txt   4938
Mailing Address C/O ALEXZA PHARMACEUTICALS, INC. 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Lippe Robert A (Reporting) CIK: 0001600757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39724 | Film No.: 221223000

Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations